Story continues below this adAccording to Fortune Business Insights, the Indian biostimulants market was valued at US$ 355.53 million in 2024 and projected to grow to US$ 1,135.96 million by 2032. The Centre’s decision is directed at one of the most common types of biostimulants: protein hydrolysate, which is a mixture of amino acids and peptides formed by breaking down proteins. These can be derived from plants, such as soy or maize, or from animal sources like feathers, hides or tissue. The animal sources they rely on include bovine hide, hair and tanned skin; chicken feathers; pig tissue; skin, bones and scales of cod; and, a variety of sardine. Story continues below this adWhen contacted, ICAR Director-General Mangi Lal Jat said permission for these animal source-based biostimulants had been “withheld”.